Literature DB >> 8360945

Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse.

A C Passaquin1, L Metzinger, J J Léger, J M Warter, P Poindron.   

Abstract

The differentiation of skeletal muscle cells from mdx mice which lack dystrophin expression was examined after glucocorticoid treatment, namely alpha-methylprednisolone (PDN). Primary skeletal muscle cell cultures were established from newborn mdx, congenic C57BL/10, and allogenic BALB/C mice. We show that PDN promotes the myogenesis of both mdx- and control mice-derived cultures as determined by 1) the number of myotubes, 2) acetylcholine receptors, and 3) dystrophin and dystrophin-related protein levels. These results support the hypothesis that PDN could enhance the myogenesis of satellite cells and increase dystrophin-related protein expression in DMD treated patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360945     DOI: 10.1002/jnr.490350403

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  A rapid preparation of primary cultures of mouse skeletal muscle cells.

Authors:  L Metzinger; P Poindron; A C Passaquin
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation.

Authors:  Sunil Pradhan; Debabrata Ghosh; Niraj Kumar Srivastava; Ashok Kumar; Balraj Mittal; Chandra Mani Pandey; Uttam Singh
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

4.  Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress.

Authors:  W J Leijendekker; A C Passaquin; L Metzinger; U T Rüegg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation.

Authors:  Shamik Sen; Manorama Tewari; Allison Zajac; Elisabeth Barton; H Lee Sweeney; Dennis E Discher
Journal:  Eur J Cell Biol       Date:  2011 Feb-Mar       Impact factor: 4.492

Review 6.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

7.  Effects of prednisolone on skeletal muscle contractility in mdx mice.

Authors:  Kristen A Baltgalvis; Jarrod A Call; Jason B Nikas; Dawn A Lowe
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

8.  Modulation by prednisolone of calcium handling in skeletal muscle cells.

Authors:  L Metzinger; A C Passaquin; W J Leijendekker; P Poindron; U T Rüegg
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study.

Authors:  Yoshiko Nakae; Katsuya Hirasaka; Junpei Goto; Takeshi Nikawa; Masayuki Shono; Mizuko Yoshida; Peter J Stoward
Journal:  Histochem Cell Biol       Date:  2008-02-09       Impact factor: 4.304

Review 10.  Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy.

Authors:  Ilaria Sanzarello; Luciano Merlini; Francesco Traina; Michele Attilio Rosa; Cesare Faldini
Journal:  Int Sch Res Notices       Date:  2014-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.